Darcy A. Krueger, MD, PhD

Director, Tuberous Sclerosis Clinic

Associate Professor, UC Department of Pediatrics


Tuberous sclerosis; general neurology


Tuberous sclerosis; clinical use of mTOR inhibitors; role of mTOR pathway in neurological disease

MD: Saint Louis University School of Medicine, St. Louis, MO, 1995-1997; 2000-2002.

PhD: Saint Louis University Graduate School Biochemistry and Molecular Biology, St. Louis, MO, 1997-2000.

View PubMed Publications

Greiner H, Leach JL, Lee KH, Krueger DA. Anti-NMDA receptor encephalitis presenting with imaging findings and clinical features mimicking Rasmussen syndrome. Seizure. 2011 Apr;20(3):266-70.

Krueger DA, Care MM, Holland K, Agricola K, Tudor C, Mangeshkar P, Wilson KA, Byars A, Sahmoud T, Franz DN. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med. 2010 Nov 4;363(19):1801-11.

Krueger DA, Franz DN. Current management of tuberous sclerosis complex. Paediatr Drugs. 2008;10(5):299-313.